hydroxyindoleacetic acid has been researched along with Cockayne Syndrome in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Cockayne Syndrome: A syndrome characterized by multiple system abnormalities including DWARFISM; PHOTOSENSITIVITY DISORDERS; PREMATURE AGING; and HEARING LOSS. It is caused by mutations of a number of autosomal recessive genes encoding proteins that involve transcriptional-coupled DNA REPAIR processes. Cockayne syndrome is classified by the severity and age of onset. Type I (classical; CSA) is early childhood onset in the second year of life; type II (congenital; CSB) is early onset at birth with severe symptoms; type III (xeroderma pigmentosum; XP) is late childhood onset with mild symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellaway, CJ | 1 |
| Duggins, A | 1 |
| Fung, VS | 1 |
| Earl, JW | 1 |
| Kamath, R | 1 |
| Parsons, PG | 1 |
| Anthony, JA | 1 |
| North, KN | 1 |
1 other study available for hydroxyindoleacetic acid and Cockayne Syndrome
| Article | Year |
|---|---|
Cockayne syndrome associated with low CSF 5-hydroxyindole acetic acid levels.
Topics: Adolescent; Cockayne Syndrome; Diagnosis, Differential; Humans; Hydroxyindoleacetic Acid; Magnetic R | 2000 |